BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3038306)

  • 21. The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines.
    Vellenga E; Biesma B; Meyer C; Wagteveld L; Esselink M; de Vries EG
    Cancer Res; 1991 Jan; 51(1):73-6. PubMed ID: 1703041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
    Marth C; Daxenbichler G; Dapunt O
    J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short- and long-term synergistic effects of human tumor necrosis factor and interferon-gamma on A549 human lung cancer cells maintained in three-dimensional culture.
    Beaupain R; Martyré MC
    Anticancer Res; 1990; 10(4):1061-6. PubMed ID: 2116752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    Ruggiero V; Tavernier J; Fiers W; Baglioni C
    J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line.
    Yamashita Y; Nara N; Aoki N
    Cancer Res; 1989 Oct; 49(19):5334-8. PubMed ID: 2548718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid.
    Bradley EC; Ruscetti FW; Steinberg H; Paradise C; Blaine K
    J Natl Cancer Inst; 1983 Dec; 71(6):1189-92. PubMed ID: 6606727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokines.
    Thorne KJ; Richardson BA; Taverne J; Williamson DJ; Vadas MA; Butterworth AE
    Eur J Immunol; 1986 Sep; 16(9):1143-9. PubMed ID: 3489622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
    Carney DN; Cuttitta F; Moody TW; Minna JD
    Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines.
    Lokshin A; Zhang H; Mayotte J; Lokshin M; Levitt ML
    Anticancer Res; 1999; 19(6B):5251-4. PubMed ID: 10697544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.
    Foulke RS; Marshall MH; Trotta PP; Von Hoff DD
    Cancer Res; 1990 Oct; 50(19):6264-7. PubMed ID: 2205378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism.
    Takizawa H; Ohtoshi T; Ohta K; Yamashita N; Hirohata S; Hirai K; Hiramatsu K; Ito K
    Cancer Res; 1993 Sep; 53(18):4175-81. PubMed ID: 8364912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells.
    Willey JC; Moser CE; Lechner JF; Harris CC
    Cancer Res; 1984 Nov; 44(11):5124-6. PubMed ID: 6488172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
    Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
    Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
    Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M; Perussia B; Trinchieri G
    Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.